Officials said 58 eye infections, including one that was fatal, were tied to artificial tears products.
The Food and Drug Administration recommended expanding a recall to include additional eye drop products due to possible contamination.
The FDA now encourages the public to immediately stop using Delsam Pharma’s Artificial Eye Ointment due to potential bacterial contamination after a previous recall of ErziCare Artificial Tears. This comes after officials said 58 eye infections, including one that was fatal, were potentially tied to the products.Global Pharma Healthcare Private Limited makes both products and initiated a recall of the products.
Officials said isolates detected VIM‐GES‐CRPA, which are highly antimicrobial drug-resistant pathogens that are uncommon in the United States, according to the National Institutes of Health. The Centers for Disease Control and Prevention said some infections caused permanent vision loss. The CDC said that most patients used artificial tears products before infection, with EzriCare Artificial Tears being the most common. The CDC said in January that testing of unopened products is ongoing.
“CDC recommends that clinicians and patients immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete,” the CDC said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
1st RSV vaccine could be approved by August, pending FDA reviewThe FDA will decide whether or not to approve an RSV vaccine designed to protect newborns by August 2023.
Lire la suite »
FDA Okays Once-Daily Tardive Dyskinesia, Huntington Chorea DrugThe FDA has approved deutetrabenazine extended-release tablets, a new once-daily formulation of the drug for adults with tardive dyskinesia or chorea associated with Huntington disease.
Lire la suite »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Lire la suite »
Pfizer RSV Vaccine That Protects Infants Could Receive FDA Approval This SummerThe single-dose RSV vaccine developed by Pfizer is administered to expectant mothers in the late second-to-third trimester of their pregnancy.
Lire la suite »
1st RSV vaccine could be approved by August, pending FDA reviewPfizer's vaccine would be the first RSV vaccine given to pregnant people to protect infants. The company said that there were 'no safety concerns' for vaccinated pregnant participants and their newborns during the trial.
Lire la suite »
FDA hasn't reviewed some food additives in decadesProposed legislation in California would ban five common chemicals from all goods sold, distributed or made in the state.
Lire la suite »